바이오 이미징 시장 : 영상 모달리티별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Bio-imaging Market size was valued at USD 6,203.43 Million in 2023, expanding at a CAGR of 16.21% from 2024 to 2032.

Bio-imaging is the scientific discipline focused on obtaining functional and structural images of the human body. It employs various techniques and processes to capture detailed snapshots of human tissues and anatomy at the molecular level. This technology plays a crucial role in the diagnosis, treatment, and prevention of diseases by utilizing advanced imaging methods. Medical bio-imaging technology is widely utilized in the examination and diagnosis of numerous diseases, contributing to the establishment of a comprehensive database of the physiology and anatomy of living organisms for further research purposes. Molecular bio-imaging specifically deals with the spatial and temporal arrangement of macromolecules, incorporating various imaging technologies ranging from X-ray, elastography, and radiography to MRI, endoscopy, tactile imaging, positron emission tomography, and ultrasound.

Bio-imaging Market- Market Dynamics

Advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies to propel market demand

The global bio-imaging market holds immense growth potential in the coming years, with the technology poised to become a cornerstone of diagnostic practices, leading to numerous innovations and business opportunities. Bio-imaging techniques are considered promising advancements in healthcare and biomedical research, expected to drive the development of cost-effective, compact, portable, and user-friendly devices. As advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies continue to progress exponentially, the demand for these technologies is anticipated to rise significantly over the next decade.The increasing burden of chronic and infectious diseases worldwide is a major driving force behind the growth of the global bio-imaging market. With rising life expectancy and changing lifestyle patterns, non-communicable diseases such as cancer, cardiovascular diseases, and neurological disorders are becoming more prevalent. For example, according to a report by the American Cancer Society in January 2022, it is projected that there will be approximately 1.9 billion new cancer cases diagnosed and 609,360 cancer-related deaths in the U.S.

Bio-imaging Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.21% over the forecast period (2024-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging was predicted to show maximum market share in the year 2023

Based on End user segmentation, and diagnostic centers was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bio-imaging Market- Segmentation Analysis:

The Global Bio-imaging Market is segmented on the basis of Imaging Modality, End user, and Region.

The market is divided into six categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound, X-ray, Others. In 2023, Magnetic Resonance Imaging (MRI) emerges as a predominant imaging modality renowned for its versatility, non-invasiveness, and exceptional spatial resolution, rendering it suitable for a broad spectrum of clinical and research End users. The technology of MRI enables detailed visualization of soft tissues, organs, and anatomical structures with remarkable contrast resolution, establishing its indispensability in diagnostic imaging across diverse medical disciplines. Furthermore, MRI's capability to furnish functional and molecular insights through methodologies like functional MRI (fMRI) and magnetic resonance spectroscopy (MRS) further amplifies its efficacy in both clinical and research domains. The extensive integration of MRI systems in hospitals, diagnostic centers, and research institutions underscores its hegemony in the bio-imaging market.

The market is divided into four categories based on End user: Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, others. In terms of the end-user segment within the bio-imaging market, hospitals and diagnostic centers emerge as the dominant segment in 2023. This predominance is attributed to the indispensable role of bio-imaging technologies in clinical diagnosis, treatment planning, and disease monitoring across a myriad of medical conditions. Hospitals and diagnostic centers function as primary healthcare facilities where patients undergo imaging assessments for the identification and management of ailments and injuries. With the escalating incidence of chronic illnesses and the burgeoning demand for advanced diagnostic imaging services, hospitals and diagnostic centers persistently invest in cutting-edge bi-imaging equipment and technologies. Furthermore, the integration of bio-imaging systems into electronic health records (EHR) and telemedicine platforms enhances their accessibility and efficacy in healthcare delivery. Consequently, hospitals and diagnostic centers remain the principal end-users propelling demand and expansion in the bio-imaging market.

Bio-imaging Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bio-imaging Market- Competitive Landscape:

In the bio-imaging market, companies frequently establish strategic partnerships to advance their imaging technologies, broaden their product offerings, and cater to diverse customer requirements. Collaborations with academic institutions and research organizations facilitate the exploration and validation of innovative imaging techniques and applications. Partnerships with healthcare providers facilitate the seamless integration of imaging systems into clinical processes, enhancing diagnostic precision and patient care. Additionally, alliances with pharmaceutical companies support drug discovery and development initiatives by offering high-throughput imaging solutions for screening and analysis.

Recent Developments:

In January 2024, Biocare Medical, a leading provider of fully automated instrumentation, announced a collaboration with Molecular Instruments(R) (MI), the creator of HCR Imaging technology. This cooperation combines Biocare Medical's skill in automated bio-imaging systems with MI's suite of advanced HCR(TM) Products, founding a new benchmark in automated in situ hybridization (ISH) and immunohistochemistry (IHC).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIO-IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bracco Imaging S.P.A

Bayer HealthCare Pharmaceuticals

Esaote S.p.A

Digirad Corporation

FONAR Corporation

GE Healthcare

Hologic Inc

Hitachi Medical Corporation

Lantheus Medical Imaging, Inc.

Covidien Pharmaceuticals

Mindray Medical International Limited

Others

GLOBAL BIO-IMAGING MARKET, BY IMAGING MODALITY - MARKET ANALYSIS, 2019 - 2032

• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Position Emission Tomography (PET)
• Ultrasound
• X-ray
• Others

GLOBAL BIO-IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals & diagnostic centers
• Academic & research institutes
• Pharmaceutical & biotech companies
• Others

GLOBAL BIO-IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Bio-imaging Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Bio-imaging Market Snippet by Image Modality
  • 2.1.2.Bio-imaging Market Snippet by End User
  • 2.1.3.Bio-imaging Market Snippet by Country
  • 2.1.4.Bio-imaging Market Snippet by Region
• 2.2.Competitive Insights

3.Bio-imaging Key Market Trends

• 3.1.Bio-imaging Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Bio-imaging Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Bio-imaging Market Opportunities
• 3.4.Bio-imaging Market Future Trends

4.Bio-imaging Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Bio-imaging Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Bio-imaging Market Landscape

• 6.1.Bio-imaging Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Bio-imaging Market - By Image Modality

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Image Modality, 2023 & 2032 (%)
  • 7.1.2.Magnetic Resonance Imaging (MRI)
  • 7.1.3.Computed Tomography (CT)
  • 7.1.4.Position Emission Tomography (PET)
  • 7.1.5.Ultrasound
  • 7.1.6.X-ray
  • 7.1.7.Others

8.Bio-imaging Market - By End User

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 8.1.2.Hospitals & diagnostic centers
  • 8.1.3.Academic & research institutes
  • 8.1.4.Pharmaceutical & biotech companies
  • 8.1.5.Others

9.Bio-imaging Market- By Geography

• 9.1.Introduction
  • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2.North America
  • 9.2.1.Overview
  • 9.2.2.Bio-imaging Key Manufacturers in North America
  • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4.North America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
  • 9.2.5.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.2.6.U.S.
    • 9.2.6.1.Overview
    • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3.U.S. Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.2.6.4.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.2.7.Canada
    • 9.2.7.1.Overview
    • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3.Canada Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.2.7.4.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 9.3.Europe
  • 9.3.1.Overview
  • 9.3.2.Bio-imaging Key Manufacturers in Europe
  • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4.Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
  • 9.3.5.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.6.Germany
    • 9.3.6.1.Overview
    • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3.Germany Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.6.4.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.7.Italy
    • 9.3.7.1.Overview
    • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3.Italy Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.7.4.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.8.United Kingdom
    • 9.3.8.1.Overview
    • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3.United Kingdom Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.8.4.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.9.France
    • 9.3.9.1.Overview
    • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3.France Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.9.4.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.10.Russia
    • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2.Russia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.10.3.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.11.Netherlands
    • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2.Netherlands Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.11.3.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.12.Sweden
    • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2.Sweden Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.12.3.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.13.Poland
    • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2.Poland Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.13.3.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.14.Rest of Europe
    • 9.3.14.1.Overview
    • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 9.4.Asia Pacific (APAC)
  • 9.4.1.Overview
  • 9.4.2.Bio-imaging Key Manufacturers in Asia Pacific
  • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4.Asia Pacific Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
  • 9.4.5.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.6.India
    • 9.4.6.1.Overview
    • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3.India Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.6.4.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.7.China
    • 9.4.7.1.Overview
    • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3.China Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.7.4.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.8.Japan
    • 9.4.8.1.Overview
    • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3.Japan Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.8.4.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.9.South Korea
    • 9.4.9.1.Overview
    • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3.South Korea Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.9.4.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.10.Australia
    • 9.4.10.1.Overview
    • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3.Australia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.10.4.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.11.Thailand
    • 9.4.11.1.Overview
    • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3.Thailand Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.11.4.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.12.Indonesia
    • 9.4.12.1.Overview
    • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3.Indonesia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.12.4.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.13.Philippines
    • 9.4.13.1.Overview
    • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3.Philippines Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.13.4.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.14.Rest of APAC
    • 9.4.14.1.Overview
    • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3.Rest of APAC Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.14.4.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 9.5.Latin America
  • 9.5.1.Overview
  • 9.5.2.Bio-imaging Key Manufacturers in Latin America
  • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4.Latin America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
  • 9.5.5.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.6.Brazil
    • 9.5.6.1.Overview
    • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3.Brazil Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.6.4.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.7.Mexico
    • 9.5.7.1.Overview
    • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3.Mexico Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.7.4.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.8.Argentina
    • 9.5.8.1.Overview
    • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3.Argentina Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.8.4.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.9.Colombia
    • 9.5.9.1.Overview
    • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3.Colombia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.9.4.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.10.Rest of LATAM
    • 9.5.10.1.Overview
    • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 9.6.Middle East and Africa
  • 9.6.1.Overview
  • 9.6.2.Bio-imaging Key Manufacturers in Middle East and Africa
  • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4.Middle East and Africa Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
  • 9.6.5.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.6.Saudi Arabia
    • 9.6.6.1.Overview
    • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.7.United Arab Emirates
    • 9.6.7.1.Overview
    • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.8.Israel
    • 9.6.8.1.Overview
    • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3.Israel Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.8.4.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.9.Turkey
    • 9.6.9.1.Overview
    • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3.Turkey Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.9.4.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.10.Algeria
    • 9.6.10.1.Overview
    • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3.Algeria Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.10.4.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.11.Egypt
    • 9.6.11.1.Overview
    • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3.Egypt Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.11.4.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.12.Rest of MEA
    • 9.6.12.1.Overview
    • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3.Rest of MEA Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.12.4.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Bio-imaging Industry

• 10.1.Competitive Dashboard
• 10.2.Company Profiles
  • 10.2.1.Bracco Imaging S.P.A
  • 10.2.2.Bayer HealthCare Pharmaceuticals
  • 10.2.3.Esaote S.p.A
  • 10.2.4.Digirad Corporation
  • 10.2.5.FONAR Corporation
  • 10.2.6.GE Healthcare
  • 10.2.7.Hologic Inc
  • 10.2.8.Hitachi Medical Corporation
  • 10.2.9.Lantheus Medical Imaging, Inc.
  • 10.2.10.Covidien Pharmaceuticals
  • 10.2.11.Mindray Medical International Limited
  • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

• 12.1.Research Methodology
• 12.2.References
• 12.3.Abbreviations
• 12.4.Disclaimer
• 12.5.Contact Us